Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Letermovir 480 mg [PREVYMIS]
DRUG
2 trials
Sponsors
University of Pennsylvania
, Jason A Roberts
Conditions
Cytomegalovirus Infections
End-Stage Kidney Disease (ESKD)
Transplant-Related Disorder
Phase 1
Pharmacokinetics of Oral Letermovir in Adults With End-Stage Kidney Disease With or Without Haemodialysis
Not yet recruiting
NCT07101055
Jason A Roberts
End-Stage Kidney Disease (ESKD)
Start: 2025-09-30
End: 2027-12-31
Target: 20
Updated: 2025-08-03
Phase 2
Open Label Trial of Oral Letermovir for CMV Prophylaxis in Thoracic Transplant Recipients
Recruiting
NCT06066957
University of Pennsylvania
Cytomegalovirus Infections, Transplant-Related Disorder
Start: 2024-04-04
End: 2026-08-15
Target: 80
Updated: 2026-06-03